The Daily Byte
Breaking
Welcome to The Daily Byte — real stories from across Pakistan.
Saturday, 21 November 2026 · Pakistan

The Daily Byte

Stories from Pakistan that deserve to be heard
Minor UK News

Medical Cannabis in the UK Explained: Who Can Get It, NHS Rules and Private Clinics

By The Daily Byte ·17 Nov 2026 ·9 min read
Close-up of green cannabis plant leaves

Medical cannabis has been legal on prescription in the United Kingdom since 1 November 2018, but only a specialist doctor can prescribe it, and on the NHS it is available to very few patients. Most people who are prescribed it get it privately. On 16 November 2026, Boots became the first UK high street pharmacy to offer a medical cannabis service, which has put the rules back in the spotlight. This guide explains what medical cannabis is, who can get it, how the NHS and private routes differ, what the evidence says, and what has changed this week.

Is medical cannabis legal in the UK?

Yes, but only on prescription. In November 2018 the Misuse of Drugs Regulations 2001 were changed to move cannabis-based products for medicinal use into Schedule 2, which allowed doctors on the General Medical Council (GMC) Specialist Register to prescribe them. Cannabis without a prescription remains illegal in the UK, whatever the reason for using it, and the government has said it has no intention of legalising cannabis for recreational use.

That distinction is important. A prescription for medical cannabis is a decision by a specialist doctor for an individual patient, based on their condition and treatment history. It is not something a person can buy, apply for, or obtain simply by asking a GP to prescribe it. There is also no official UK cannabis card, licence or registry: anything sold as one is not a legal route to treatment.

What is medical cannabis?

Medical cannabis is a broad term for cannabis-based medicines prescribed by a doctor. They can contain THC, CBD, or both, and they come in several forms, including oils, capsules, pastilles and dried flower for use in a medical vaporiser. They are different from the CBD oil sold in health shops, which is a food supplement, not a medicine, and makes no licensed health claims.

Only three cannabis-based medicines hold a full UK marketing authorisation, meaning they are licensed for specific uses. Everything else prescribed in the UK is unlicensed, supplied as a "special" medicine for an individual patient where a specialist judges that no licensed medicine can meet their clinical needs.

What can be prescribed on the NHS?

NHS prescribing is very limited. The NHS says medical cannabis can only be prescribed on the NHS by a specialist hospital doctor, or under a specialist's supervision, and it is only likely to be prescribed for three groups of patients, and only when other treatments have not worked or are not suitable.

The first is Epidyolex, a highly purified liquid containing CBD, for children and adults with rare, severe forms of epilepsy: Lennox-Gastaut syndrome and Dravet syndrome, taken alongside the drug clobazam, and seizures in tuberous sclerosis complex. The second is Sativex, also known as nabiximols, a THC and CBD mouth spray for adults with moderate to severe muscle stiffness and spasms caused by multiple sclerosis, where other treatments have not worked well enough. The third is nabilone, a synthetic cannabinoid similar to THC, in capsules, for adults with nausea and vomiting caused by chemotherapy that usual anti-sickness medicines have not controlled.

Those are the only licensed uses, and NHS prescribing outside them is extremely rare. In the year to January 2025, the NHS in England issued 5,413 prescriptions for licensed cannabis medicines to 880 patients. Prescribing of unlicensed cannabis products on the NHS is so unusual that the figures are withheld because fewer than five patients were involved.

The National Institute for Health and Care Excellence (NICE) sets out the position in its guideline NG144, published in November 2019 and reviewed in May 2025. NICE says doctors should not offer nabilone, dronabinol, THC, or a combination of CBD with THC to manage chronic pain in adults, and it was unable to recommend cannabis-based medicines for chronic pain outside a clinical trial. No cannabis-based medicine is licensed in the UK for Parkinson's disease, anxiety, insomnia or chronic pain.

Who can prescribe it?

Only a doctor on the GMC Specialist Register can start a prescription for an unlicensed cannabis product. That rule is written into the Misuse of Drugs Regulations 2001. A GP cannot start a prescription, although after the first one a GP may sometimes continue it under a shared care agreement with the specialist. The specialist must be prescribing within their own area of practice, and the NHS says a hospital specialist might consider prescribing medical cannabis only when it is believed to be in the patient's best interests and other treatments have not worked.

Private clinics work under the same prescribing law. A private clinic must be registered with the Care Quality Commission (CQC) in England, or the equivalent regulator in Scotland, Wales or Northern Ireland, and its doctors must be on the Specialist Register.

The private route: how most patients get it

Most people in the UK who are prescribed medical cannabis get it privately, through a clinic with specialist doctors. Private prescriptions run into the hundreds of thousands, compared with a few thousand on the NHS. Patients pay for consultations and medication themselves, and the clinic assesses each person case by case.

Private clinics usually consider adults with a diagnosed long-term condition whose symptoms have not been adequately controlled by at least two standard treatments that have been properly tried. The conditions most often considered include chronic pain, anxiety disorders, insomnia and post-traumatic stress disorder, but a clinic will only prescribe if a specialist judges it clinically appropriate for that individual. A prescription is valid for 28 days from its date.

Anyone considering the private route should check that the clinic is registered with the CQC, that the doctor is a GMC-registered specialist, and that the costs of consultations, follow-up appointments and medication are clear in advance. A legitimate clinic will carry out a full medical assessment first; a prescription is never automatic.

Boots SureLeaf: what has changed this week?

On 16 November 2026, Boots UK announced that its Boots Online Doctor platform had launched SureLeaf, a specialist doctor-led medical cannabis service, making Boots the first UK high street pharmacy to offer access to the treatment. The service is for people aged 25 and over living with eligible chronic pain conditions, generalised anxiety disorder or insomnia, who have tried conventional treatments without adequate relief.

Patients begin with an online assessment, which a clinical team reviews before arranging a video consultation with a consultant on the GMC Specialist Register. A multidisciplinary team, including a second independent consultant, reviews any proposed prescription. Products are sold by mail order rather than through Boots shops. A one-month trial, including a specialist review, costs £89, and an annual plan costs £99, with medication charged separately. Boots says it is working with UK suppliers and is exploring a research programme with the University of Nottingham into patient outcomes in chronic pain.

The launch does not change the law, and it does not make medical cannabis available on the NHS. SureLeaf is a private service, and its age limit of 25 is Boots' own policy: there is no legal requirement for medical cannabis patients to be over 25, and other clinics accept patients aged 18 and over. The launch does, however, bring a familiar high street name into a market that has until now been served mainly by specialist online clinics, which is why it has drawn wide attention.

What does the evidence say?

The evidence for medical cannabis is still developing, and it differs sharply by condition. For the three licensed uses on the NHS, the evidence was judged strong enough for a licence. For other conditions, it is weaker. A Cochrane review published in January 2026 found no clear evidence that cannabis-based medicines are a successful treatment for chronic pain. A review of more than 50 randomised controlled trials published earlier this year concluded there was no evidence that medicinal cannabis was an effective treatment for some common mental health conditions such as depression, anxiety or post-traumatic stress disorder, although the researchers said more research was needed.

The NHS says there is some evidence that medical cannabis can help certain types of pain, but not enough to recommend it for pain relief. That is the tension at the heart of the private market: clinics prescribe for chronic pain, anxiety and insomnia, while the official guidance says the evidence does not yet support those uses. Patients should weigh that carefully and discuss it with a specialist, rather than relying on advertising or anecdotes.

Medical cannabis and CBD oil: what is the difference?

Shop-bought CBD oil is not medical cannabis. It is sold as a food supplement, it contains little or no THC, and it has no licensed medical use. Its quality and content are not regulated as a medicine, and the NHS warns that many cannabis-based products available to buy online may be illegal and potentially dangerous.

Medical cannabis, by contrast, is a prescribed medicine with a known composition, dispensed by a pharmacy against a specialist prescription. The two should not be confused, and CBD oil from a shop is not a substitute for a prescription.

Driving, travel and safety

Prescribed medical cannabis can affect concentration and reaction times, so patients should discuss driving with their specialist and follow medical advice. Anyone taking a prescribed cannabis-based medicine should also check the rules before travelling abroad, because the law on medical cannabis differs from country to country and a UK prescription is not automatically recognised elsewhere. As with any medicine, patients should tell their doctor about all other medicines they take and report side effects.

Frequently asked questions

Can I get medical cannabis on the NHS? It is possible but uncommon. NHS prescribing is mainly limited to three licensed medicines for rare severe epilepsy, multiple sclerosis spasticity and chemotherapy sickness, and only when other treatments have not worked.

Can my GP prescribe medical cannabis? No. Only a doctor on the GMC Specialist Register can start a prescription. A GP may continue one under a specialist's supervision.

Is medical cannabis the same as CBD oil from a shop? No. Shop-bought CBD oil is a food supplement with no licensed medical use. Medical cannabis is a prescribed medicine.

Is recreational cannabis legal in the UK? No. Possessing cannabis is illegal, whatever the reason, unless it has been prescribed for you.

What is Boots SureLeaf? A private medical cannabis service launched by Boots Online Doctor on 16 November 2026, for patients aged 25 and over with eligible chronic pain, generalised anxiety disorder or insomnia. It is not an NHS service.

Sources: NHS, Medical cannabis (and cannabis oils); The Pharmaceutical Journal, "Boots launches online medical cannabis prescribing service" (16 November 2026); NICE guideline NG144, Cannabis-based medicinal products. This article is general information, not medical advice. Anyone considering medical cannabis should speak to their GP or a specialist.